Probiotic BC99 shows promise for gut health in overweight adults
NCT ID NCT06077383
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether a probiotic called Weizmania Coagulans BC99 can improve gut bacteria and blood fat markers (like cholesterol) in overweight adults. 72 participants took either the probiotic or a placebo daily for 8 weeks. Researchers collected blood, urine, and stool samples to measure changes. The goal was to see if this probiotic could help manage weight-related health risks.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OVERWEIGHT are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Qilu hospital
Jinan, Shandong, 250012, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a Two-Drug combo tip the scales against obesity?
- Can patients power their own obesity research?
- Does when you eat carbs and protein reshape blood sugar control?
- Can a weekly shot keep metabolism from slowing after weight loss?
- Can Early-Life factors steer preterm and term infant health?
- Can a new injection help tackle obesity? a trial investigates